"Repressor Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins which maintain the transcriptional quiescence of specific GENES or OPERONS. Classical repressor proteins are DNA-binding proteins that are normally bound to the OPERATOR REGION of an operon, or the ENHANCER SEQUENCES of a gene until a signal occurs that causes their release.
| Descriptor ID |
D012097
|
| MeSH Number(s) |
D12.776.260.703 D12.776.930.780
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Repressor Proteins".
Below are MeSH descriptors whose meaning is more specific than "Repressor Proteins".
This graph shows the total number of publications written about "Repressor Proteins" by people in this website by year, and whether "Repressor Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1994 | 4 | 1 | 5 |
| 1995 | 3 | 2 | 5 |
| 1996 | 2 | 1 | 3 |
| 1997 | 1 | 0 | 1 |
| 1998 | 7 | 0 | 7 |
| 1999 | 2 | 5 | 7 |
| 2000 | 6 | 4 | 10 |
| 2001 | 4 | 4 | 8 |
| 2002 | 11 | 5 | 16 |
| 2003 | 7 | 2 | 9 |
| 2004 | 10 | 2 | 12 |
| 2005 | 7 | 4 | 11 |
| 2006 | 8 | 5 | 13 |
| 2007 | 7 | 3 | 10 |
| 2008 | 7 | 6 | 13 |
| 2009 | 7 | 3 | 10 |
| 2010 | 12 | 13 | 25 |
| 2011 | 10 | 2 | 12 |
| 2012 | 14 | 7 | 21 |
| 2013 | 22 | 4 | 26 |
| 2014 | 6 | 7 | 13 |
| 2015 | 16 | 2 | 18 |
| 2016 | 4 | 3 | 7 |
| 2017 | 10 | 3 | 13 |
| 2018 | 8 | 2 | 10 |
| 2019 | 6 | 3 | 9 |
| 2020 | 6 | 4 | 10 |
| 2021 | 4 | 2 | 6 |
| 2022 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Repressor Proteins" by people in Profiles.
-
The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors. Cell Mol Life Sci. 2022 May 09; 79(6):285.
-
The significance of CUX1 and chromosome 7 in myeloid malignancies. Curr Opin Hematol. 2022 03 01; 29(2):92-102.
-
Incomplete bladder emptying and urinary tract infections after botulinum toxin injection for overactive bladder: Multi-institutional collaboration from the SUFU research network. Neurourol Urodyn. 2022 02; 41(2):662-671.
-
Genomic studies controvert the existence of the CUX1 p75 isoform. Sci Rep. 2022 01 07; 12(1):151.
-
Loss of a 7q gene, CUX1, disrupts epigenetically driven DNA repair and drives therapy-related myeloid neoplasms. Blood. 2021 09 02; 138(9):790-805.
-
Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia. Cancer Discov. 2021 11; 11(11):2846-2867.
-
Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell model. Stem Cell Reports. 2021 06 08; 16(6):1458-1467.
-
Progenitor cell diversity in the developing mouse neocortex. Proc Natl Acad Sci U S A. 2021 03 09; 118(10).
-
Persistent antigen exposure via the eryptotic pathway drives terminal T cell dysfunction. Sci Immunol. 2021 02 26; 6(56).
-
WHSC1/NSD2 regulates immune infiltration in prostate cancer. J Immunother Cancer. 2021 02; 9(2).